The EU funds research, innovation and market-entry projects through non-dilutive grant programmes. RX Capital helps U.S. and international companies find the right EU funding route, build the European consortium, and manage the process end-to-end — from first assessment to compliant delivery.
RX Capital helps U.S. technology, research and innovation companies access EU non-dilutive funding, build European partnerships and create a compliant project route into the EU market.
You bring the technology. We build the European funding path.
Every year the EU distributes tens of billions of euros for innovation, research and growth — non-dilutive, no equity. Yet most companies never reach it. The programmes are complex, the applications demanding, the partners hard to find.
That is the gap we close. RX Capital builds and manages the funding process — from first assessment to application, consortium coordination and compliant project delivery. We don't just write a document and walk away; we map the route, build the consortium, prepare a competitive application, and support the project through to delivery.
We work the way the best partners do: with discretion, responsibility and a single focus — turning a fundable idea into a structured European project.
— Adrian Rexa, Founder & Owner, RX Capital
Programme references only. RX Capital is an independent advisory firm and does not imply endorsement by, or partnership with, the named institutions.
We identify the right programme and prepare a competitive, non-dilutive EU grant application for your project.
Many programmes require a consortium. We source the right universities, institutions and companies across the EU.
After approval, we support procurement, reporting, compliance and project coordination. You get a managed process, not paperwork.
We review your company, technology, market and funding fit.
We identify the best EU programme, expected budget, partners and timeline.
We source the European partners or consortium structure the call requires.
We prepare the application, budget, work packages and documentation.
After approval, we support procurement, reporting, compliance and coordination.
A company develops a new technology and wants to turn it into a product — but doesn't know how to access funding, find partners, or prepare the application.
We map the right programme, build the consortium, and prepare a competitive application. The funding is non-dilutive — and the company keeps full ownership of its idea and IP.
Illustrative example based on a real type of EU funding opportunity. Actual eligibility, funding rate, budget, consortium requirements and approval depend on the specific programme, call conditions and evaluation outcome.
I spent years inside the EU funding world — preparing applications, coordinating projects and working with the programmes that move billions of euros every year. And I kept seeing the same thing: brilliant companies with real technology walking away from non-dilutive funding they were genuinely eligible for, simply because the path looked too complex.
The money is there. The programmes are there. What's missing is someone who takes a company by the hand and builds the whole route — the right programme, the right partners, a competitive application, and the delivery afterwards. Not a consultant who writes a document and disappears, but a partner who owns the path from idea to funded project.
That's why I started RX Capital. I believe great ideas deserve to be built — and that European funding should be a door that's open, not a wall. My job is to open that door for the companies that are ready to walk through it.
Adrian works in EU project funding, grant preparation and project coordination, with experience across funding strategy, application processes, procurement, implementation and compliance. Through RX Capital, he helps international companies turn fundable ideas into structured EU project opportunities and build the right European route for funding and delivery.
Know companies with an idea worth funding? Become an RX Capital partner. You make the introduction — we build the funding route — and you earn from every project that moves forward.
Become a partner →The first step is simple: we check eligibility, identify the right programme, map the funding route and partners, and give you a clear view of the next steps.
Request your assessment →Let us check whether it can become a structured EU funding opportunity. Start with a short, no-obligation assessment and receive a clear view of the funding route, partner needs and next steps.
contact@rxcapital.eu